Clinical Trials

Prostatic Neoplasms

NCT03581240 2026-02-20

An Intermediate Expanded Use Trial of DFMO

Typical Teratoid Rhabdoid Tumor, Medulloblastoma, Neuroblastoma, Neuroectodermal Tumors, Primitive

NCT00590915 2026-01-23

EMTP

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06963697 2026-01-15

Expanded Access To Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors

Tumor-Agnostic

Neoplasms

NCT03626285 2026-01-02

Bone Marrow Transplantation Using CD34-Selected Stem Cells From Related or Unrelated Donors in Treating Participants With Cancer or Other Disorders

Tumor-Agnostic

Neoplasms

NCT07262970 2025-12-04

Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor

EndocrineNETSarcoma

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

NCT01881334 2025-11-20

Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Adrenoleukodystrophy, Anemia, Aplastic, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Lymphoma, Metabolic Diseases, Myelodysplastic Syndromes, Thalassemia, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05389514 2025-11-20

Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors

Temporarily not available

KRAS G12V Mutant Advanced Epithelial Cancers

NCT07223606 2025-11-03

Fecal Microbiota Transplant for Neuroblastoma in a Single Patient

Neuroblastoma, Dysbiosis

NCT07218224 2025-10-20

Expanded Access:18F-Fluorocholine for the Detection of Parathyroid Adenomas

Head & Neck

Parathyroid Neoplasms

NCT05511714 2025-10-16

Expanded Access [11C] Methionine PET Imaging

CNSHead & Neck

Head and Neck Neoplasms, Central Nervous System Neoplasms

NCT04008524 2025-08-06

A Clinical Study of CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies

Other hematologic neoplasm

Recurrence, Hematologic Neoplasms

NCT07104591 2025-08-05

TETRAVI Expanded Access Program

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT05064306 2025-08-01

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Medulloblastoma, Meningeal Neoplasms, Wilms Tumor, Neuroblastoma, Pinealoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

NCT01163383 2025-07-25

131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol

Neuroblastoma

NCT01370330 2025-07-22

131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol

Neoplasms, Neuroblastoma, Recurrence

NCT03493152 2025-05-28

Expanded Access to Everolimus, for an Individual Patient With GIST (Gastrointestinal Stromal Tumors)(CTMS#18-0019)

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT03145545 2025-05-22

Expanded Access Protocol Using Alpha/Beta T and CD19+ Depleted PBSC

Other hematologic neoplasm

Bone Marrow Failure Disorders, Immunologic Deficiency Syndromes, Leukemia

NCT01916148 2025-04-02

18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia

Endocrine

Beckwith-Wiedemann Syndrome, Hyperinsulinism, Hypoglycemia, Insulinoma, Congenital Hyperinsulinism

NCT02158767 2025-03-12

Access Protocol. Infusion of CD34+ Enriched, T Cell Depleted Hematopoietic Stem Cell Grafts.

Other hematologic neoplasm

Hematologic Neoplasms

NCT06676891 2025-01-08

Expanded Access Program for GBM Subjects

Glioblastoma

NCT05941637 2024-12-31

An Expanded Access Program to Axitinib is Available for Patients With Advanced Forms of Kidney Cancer (Ductal; Papillary; Chromophobic; Oncocytic) With Mutations in VHL, PBRM1 / BAP1, SETD2, VEGF)

Kidney Neoplasms

NCT04809584 2024-12-19

18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate Cancer

Prostatic Neoplasms

NCT03649438 2024-12-11

131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory Neuroblastoma

CNSEndocrine

Neuroblastoma, Pheochromocytoma

NCT06439849 2024-07-16

TRIANGLE

Diffuse Intrinsic Pontine Glioma

NCT03015844 2024-07-05

A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma

CNSEndocrine

Neuroblastoma, Pheochromocytoma, Recurrence

NCT05014607 2024-05-09

InHeVac01

Tumor-Agnostic

Neoplasms

NCT03914872 2024-03-12

Expanded Access Neoantigen Vaccine in Solid Tumors

Other solid neoplasm

Solid Tumor, Adult

NCT05356312 2024-03-01

Glioblastoma and Individualized Therapies

Glioma

NCT03941782 2024-01-11

Compassionate Use of BYL 719 Alpelisib

Lymphangioma

NCT00906984 2024-01-08

TheraSphere

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05002465 2023-09-11

Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer

Prostatic Neoplasms

NCT01838187 2023-08-18

Expanded Access Protocol Using 131I-MIBG Therapy +/- Vorinostat for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma

CNSEndocrine

Neuroblastoma, Paraganglioma, Pheochromocytoma

NCT05415228 2023-05-18

Expanded Access to Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrent Prostate Cancer

Prostatic Neoplasms

NCT04854369 2023-04-11

Firefly

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT02960620 2022-09-28

Therasphere for Unresectable Primary or Secondary Liver Neoplasia

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT00872950 2022-04-11

LEMS

Lambert-Eaton Myasthenic Syndrome, Myasthenic Syndromes, Congenital

NCT04452136 2022-03-14

Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer

Prostatic Diseases, Prostatic Neoplasms

NCT03501940 2022-01-21

F18 DCFPyL PET/CT in Imaging Participants With Recurrent Prostate Cancer

Prostatic Neoplasms

NCT04800068 2022-01-21

Expanded Access [Ga-68] PSMA-11 PET Imaging

Prostatic Neoplasms

NCT03594162 2021-12-03

Compassionate Use of CAR T Cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Switch

LymphoidOther hematologic neoplasm

Immune System Diseases, Immunoproliferative Disorders, Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03914885 2021-12-03

Compassionate Use Re-Infusion of ATLCAR.CD30

Lymphoid

Hodgkin Disease

NCT01825395 2021-10-06

3 4-DAP

Lambert-Eaton Myasthenic Syndrome

NCT02449135 2021-09-09

Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Carcinoma

Gastrointestinal

Pancreatic Neoplasms

NCT02985658 2021-07-21

Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer

Breast

Triple Negative Breast Neoplasms

NCT04348682 2021-06-24

Expanded Access Protocol of 68Ga-PSMA-11 for PET Imaging

Prostatic Neoplasms

NCT01200017 2021-05-27

Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant

Classical hematologyLymphoidMyeloidOther hematologic neoplasmOther neoplasm

Bone Marrow Failure Disorders, Cytopenia, Bone Diseases, Bone Diseases, Developmental, Bone Marrow Diseases, Graft vs Host Disease, Hematologic Diseases, Hemoglobinopathies, Immunologic Deficiency Syndromes, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Lymphoid, Leukemia, Myeloid, Leukocyte Disorders, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Musculoskeletal Diseases, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Osteochondrodysplasias, Osteopetrosis, Osteosclerosis, Pancytopenia, Precancerous Conditions, Preleukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Genetic Diseases, Inborn, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04377152 2021-03-01

Expanded Access 68Gallium-PSMA-11 PET for Prostate Cancer